Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

BACKGROUND: PALETTE is a phase 3 trial that demonstrated single-agent activity of pazopanib in advanced soft tissue sarcomas (aSTS). We performed retrospective subgroup analyses to explore potential relationships between patient characteristics, prior lines of therapy, dose intensity, and dose modif...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Cesne, Axel Le, Bauer, Sebastian, Demetri, George D., Han, Guangyang, Dezzani, Luca, Ahmad, Qasim, Blay, Jean-Yves, Judson, Ian, Schöffski, Patrick, Aglietta, Massimo, Hohenberger, Peter, Gelderblom, Hans
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691522/
https://ncbi.nlm.nih.gov/pubmed/31409302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5988-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi